These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 31190353

  • 1. Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
    Song G, Tian L, Cheng Y, Liu J, Wang K, Li S, Li T.
    J Cell Biochem; 2019 Oct; 120(10):18152-18161. PubMed ID: 31190353
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 3. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
    Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X.
    PLoS One; 2011 May 05; 6(5):e19518. PubMed ID: 21573166
    [Abstract] [Full Text] [Related]

  • 4. lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis.
    Zhou W, Li H, Shang S, Liu F.
    Braz J Med Biol Res; 2021 May 05; 54(7):e10213. PubMed ID: 34008749
    [Abstract] [Full Text] [Related]

  • 5. microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
    Sun Y, Liu L, Xing W, Sun H.
    Cell Signal; 2021 Jul 05; 83():109982. PubMed ID: 33741494
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.
    Tumour Biol; 2016 May 05; 37(5):5885-95. PubMed ID: 26589417
    [Abstract] [Full Text] [Related]

  • 7. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 05; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 8. Sevoflurane inhibits the proliferation and invasion of hepatocellular carcinoma cells through regulating the PTEN/Akt/GSK‑3β/β‑catenin signaling pathway by downregulating miR‑25‑3p.
    Cao Y, Lv W, Ding W, Li J.
    Int J Mol Med; 2020 Jul 05; 46(1):97-106. PubMed ID: 32319540
    [Abstract] [Full Text] [Related]

  • 9. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G, Liu X, Li H, Yan Y, Hong X, Lin Z.
    Int J Immunopathol Pharmacol; 2018 Jul 05; 32():2058738418814341. PubMed ID: 30477356
    [Abstract] [Full Text] [Related]

  • 10. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL, Wang HB, Yong JK, Zhong J, Li QH.
    Eur Rev Med Pharmacol Sci; 2018 Oct 05; 22(20):6667-6677. PubMed ID: 30402839
    [Abstract] [Full Text] [Related]

  • 11. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
    Ding L, Wang RY, Zhang F, Wu MS, Chen B, Sun KW.
    Zhongguo Zhong Yao Za Zhi; 2024 Feb 05; 49(4):1073-1081. PubMed ID: 38621914
    [Abstract] [Full Text] [Related]

  • 12. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
    Qadir XV, Han C, Lu D, Zhang J, Wu T.
    Am J Pathol; 2014 Aug 05; 184(8):2355-64. PubMed ID: 24911372
    [Abstract] [Full Text] [Related]

  • 13. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH, Jin M, Wang LQ, Xu GJ, Lin ZY, Yu DD, Yang SL, Ran RZ, Wu G, Zhang T.
    J Cell Physiol; 2020 Sep 05; 235(9):6154-6166. PubMed ID: 32020591
    [Abstract] [Full Text] [Related]

  • 14. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
    Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T, Wen H, Yang Y, Wang S, Wang J, Nan K, Yao Y, Tian T.
    J Exp Clin Cancer Res; 2018 Mar 12; 37(1):52. PubMed ID: 29530052
    [Abstract] [Full Text] [Related]

  • 15. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 12; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
    Ohta K, Hoshino H, Wang J, Ono S, Iida Y, Hata K, Huang SK, Colquhoun S, Hoon DS.
    Oncotarget; 2015 Feb 20; 6(5):3211-24. PubMed ID: 25633810
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J, Cheng J, Zeng Z, Wang Y, Li X, Xie Q, Jia J, Yan Y, Guo Z, Gao J, Yao M, Chen X, Lu F.
    Oncotarget; 2015 Dec 08; 6(39):42040-52. PubMed ID: 26547929
    [Abstract] [Full Text] [Related]

  • 18. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 19. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
    Xiao ZD, Jiao CY, Huang HT, He LJ, Zhao JJ, Lu ZY, Liu LX.
    Int J Clin Exp Pathol; 2014 Oct 06; 7(7):4039-44. PubMed ID: 25120782
    [Abstract] [Full Text] [Related]

  • 20. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
    Wang H, Zhang Q, Cui W, Li W, Zhang J.
    Cell Cycle; 2021 Oct 06; 20(20):2125-2136. PubMed ID: 34570663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.